AGP Executive Report
Last update: 12 hours agoReproductive Health Policy: Liechtenstein’s parliament narrowly approved a bill to legalise abortion up to 12 weeks, but the Hereditary Prince Alois has signalled he would veto it—meaning the law’s future hinges on whether he signs within six months. Healthcare Law Details: The current rules are among Europe’s strictest, with limited exceptions and even restrictions on sharing information about abortion services abroad. EU Health & Mobility Context: Truck drivers from the Western Balkans are threatening border blockades over Schengen entry/exit limits, a dispute that also affects Liechtenstein as part of the Schengen area. Metabolic Disease Drug Deal: Menarini agreed to pay €62m up front plus up to €664m in milestones to develop and commercialise Gan & Lee’s GLP-1 bofanglutide across Europe and beyond, including Liechtenstein. Workforce & Training: UK policy changes prioritising NHS-trained medical graduates sharply increased “homegrown” uptake for specialty training places.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
